Abstract: A method of risk stratification for contagious disease is provided. The method performs a reverse transcriptase polymerase chain reaction (RT-PCR) test on a patient to determine the presence of a viral infection. The method next performs tests for the presence of antibody Immunoglobulin M (IgM) and Immunoglobulin G (IgG) assays. The method assigns the patient a level of readiness to return to society corresponding to the combination of the results of the qualitative RT-PCR, IgM, and IgG tests and quantitative IgG+ antibody testing. The levels of readiness to return to society may be verified by a QR code on a mobile device.

Abstract: The disclosed technology includes systems, methods, apparatuses, and computer-readable mediums for facilitating electronic analysis of medication related data and providing detailed analysis in a comprehensible format for access by ordinary, non-expert individuals (“the disclosed technology”). Briefly described, the disclosed technology includes processing and aggregating, from different data sources, laboratory data (e.g., DNA test results), medication data (e.g., list of medications), and/or medical history data, analyzing the different data to create medication pathway mappings associated with a patient's medical profile, and delivering, to the patient, real-time detailed analysis of adverse drug interactions and/or adverse prescribed treatments based on the medication pathway mappings.